Efficacy test of Trichoben vaccine administered to calves at different intervals between vaccination and re-vaccination

被引:2
|
作者
Rybnikar, A. [1 ]
Oborilova, E. [1 ]
Hedbavny, R. [1 ]
机构
[1] Bioveta AS, Ivanovice Na Hane 68323, Czech Republic
关键词
cattle; post-vaccination immunity; challenge; Trichophyton verrucosum;
D O I
10.2754/avb200877020239
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The aim of the study was to test a possible extension of the period between vaccination and re-vaccination with the live Trichoben vaccine (Bioveta, a.s., Czech Republic). The calves (n = 61) were vaccinated intramuscularly. The intervals between vaccination and re-vaccination were 3, 5, 7, 10, 14 or 28 days. Another group of calves (n = 16) was vaccinated once with a double dose of the vaccine. The protective immunity against experimental infection with a virulent Trichophyton verrucosum CCM F-650 strain was investigated in animals one month after the last vaccination and compared with a group of non-vaccinated controls (n = 16). Clinical results were evaluated and compared using balanced two-way-ANOVA. The level of post-vaccination immunity in cattle after re-vaccination was sufficient when the intervals were 5, 7, 10, 14 and 28 days. One-time injection of a double prophylactic dose of the vaccine and a 3-day interval between vaccinations reduced the immunity and vaccine efficacy to an unsatisfactory degree. There were significant differences between the groups of calves vaccinated using an interval longer than 5 days, and the group vaccinated once with a double dose, and the group with a 3-day interval between vaccinations. The level of post-vaccination immunity in cattle after re-vaccination at the commonly used interval of 10 - 14 days was identical with the immunity achieved when the interval was reduced to 5 or 7 days or extended up to 28 days. The extension of the interval between vaccinations to 5 - 28 days is recommended for using the Trichoben vaccine in veterinary practice.
引用
收藏
页码:239 / 243
页数:5
相关论文
共 50 条
  • [1] PNEUMOCOCCAL VACCINE - RE-VACCINATION RECOMMENDATIONS
    BROOME, CV
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (12): : 1744 - 1744
  • [4] Efficacy of Hepatitis B Vaccination and Re-Vaccination and Factors Impacting on the Response in Inflammatory Bowel Disease Patients
    Gisbert, Javier P.
    Villagrasa, Jose R.
    Nogueiras, Amelia Rodriguez
    Chaparro, Maria
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S362 - S362
  • [5] Duration of Immunity Conferred by Typhoid Vaccine Results of Re-vaccination by Intracutaneous Injection of Typhoid Vaccine
    Siler, J. F.
    Dunham, G. C.
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH, 1939, 29 (02): : 95 - 103
  • [6] Re-vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunisation service
    Gold, M
    Goodwin, H
    Botham, S
    Burgess, M
    Nash, M
    Kempe, A
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2000, 83 (02) : 128 - 131
  • [7] Aerosol and subcutaneous measles vaccine: Measles antibody responses 6 years after re-vaccination
    Dilraj, Athmanundh
    Sukhoo, Reshma
    Cutts, Felicity T.
    Bennett, John V.
    [J]. VACCINE, 2007, 25 (21) : 4170 - 4174
  • [8] Protective Efficacy of BCG Vaccination in Calves Vaccinated at Different Ages
    Hope, Jayne C.
    Khalid, Hamza
    Thom, Michelle L.
    Howard, Chris J.
    Shaw, Darren J.
    [J]. PATHOGENS, 2023, 12 (06):
  • [9] Predictive effect of five hepatitis B virus markers on re-vaccination time of hepatitis B vaccine
    Jia, Qiuhua
    Yu, Fei
    Zhou, Qi
    Chen, Xiaoyan
    Gu, Zhaoqi
    Ma, Chunling
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (02) : 1709 - 1715
  • [10] Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella
    Tischer, A
    Gerike, E
    [J]. VACCINE, 2000, 18 (14) : 1382 - 1392